Dr Alan Taylor joined Clarity as Executive Chair in November 2013 when the company was in its early infancy as an incorporated entity with two provisional patents, and has been instrumental in the growth of the company to where it is today, with a market capitalisation of approximately $2 billion, having completed one of the largest life sciences IPOs ever on the ASX in 2021. Dr Taylor is a scientist by training, and has 15 years of investment banking experience, focused predominantly on the life sciences sector, and has significant expertise in capital raisings, mergers and acquisitions, and general corporate advisory. Prior to joining Clarity, Dr Taylor was an Executive Director of Inteq Limited, a boutique Australian investment bank.
Dr Taylor was awarded the University Medal with his Undergraduate degree in Applied Science at the University of Sydney and completed his PhD in Medicine at the Garvan Institute of Medical Research. He has also completed a Graduate Diploma in Applied Finance at the Securities Institute of Australia.
